Microbiome Sequencing Market By Technique (Shotgun sequencing, RNA sequencing, Targeted gene sequencing, Whole genome sequencing, Others), By Research (Outsourced, Internal), By End user (Pharmaceutical and biotechnological companies, Academic institutes

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,840	235 Pages	Allied Market Research	December, 2022	ALMR17759200

Best Price Guarantee
Price	from $3,840
Length	235 Pages
Publisher	Allied Market Research
Published Date	December, 2022
SKU	ALMR17759200

Microbiome Sequencing Market By Technique (Shotgun sequencing, RNA sequencing, Targeted gene sequencing, Whole genome sequencing, Others), By Research (Outsourced, Internal), By End user (Pharmaceutical and biotechnological companies, Academic institutes and research centers): Global Opportunity Analysis and Industry Forecast, 2021-2031

The microbiome sequencing market size was valued for $859.42 million in 2021 and is estimated to reach $3,417.09 million by 2031, exhibiting a CAGR of 14.8% from 2022 to 2031.

Microbiome sequencing is a technique used for decoding the genetic material of all the bacteria, viruses, fungi, and protists in a sample. In addition, microbial sequencing is essential as microbiome is the key to illuminate the structure and functions of specific microbial communities, which is particularly important because many human diseases are linked to the alternation of human microbiome composition. Sequencing of bacterial genomes has significantly improved understanding of bacterial phylogeny and taxonomy. The microbial sequencing allows the detection of variations within the target genomes and interpretation of genetic material in bacteria, virus, fungi, and protists present in the sample.

The driving factors for microbiome sequencing market are use of microbiome sequencing in early disease diagnosis and utilization of this technology in development of personalized medicines for various diseases. For instance, according to article published in Frontiers in Cellular and Infection Microbiology 2021, understanding of the microbiome in pancreatic cancer patients, as well as its manipulation helps in diagnosis and treatment of pancreatic cancer. Further, new therapeutic approaches, called personalized medicine, have opened a new window in medical science, which drives the growth of market. The association between the microbiome and personalized medicine appears to be one of the most interesting aspects of the subsequent research and has a crucial perspective on the treatment of diseases such as cancer and infectious disease. In addition, rise in use of microbiome sequencing in genomics, proteomics, and metabolomics is anticipated to drive the growth of market.

However, factor such as the lack of skilled persons in the operating system of microbiome sequencing restrains the growth of microbiome sequencing market. In addition, stringent rules, and regulations by the governments for microbiome sequencing, also might hinder the growth of market.

The microbiome sequencing market is segmented into technique, research, end user, and region. By technique, the market is categorized into shotgun sequencing, RNA sequencing, targeted gene sequencing, whole-genome sequencing, and others. On the basis of research, the market is segregated into outsourced and internal. On the basis of end user, the market is classified into pharmaceutical &biotechnology companies and Academic Institutes & Research centers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major Key players that operate in the global microbiome sequencing market are Baseclear BV, Charles River Laboratories International, Inc., Clinical Microbiomics, CosmosID, Microbiome Insights, Molecular Research LP, Novogene Co., Ltd., OraSure Technologies (Diversigen), Resphera Biosciences Llc and Zymo Research Corporation.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the microbiome sequencing market analysis from 2021 to 2031 to identify the prevailing microbiome sequencing market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the microbiome sequencing market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global microbiome sequencing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Technique

Shotgun sequencing
RNA sequencing
Targeted gene sequencing
Whole genome sequencing
Others

By Research

Outsourced
Internal

By End user

Pharmaceutical and biotechnological companies
Academic institutes and research centers

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA

Key Market Players

Microbiome Insights
Clinical Microbiomics
Baseclear BV
CosmosID
Novogene Co., Ltd.
Zymo Research Corporation
Resphera Biosciences, LLC
OraSure Technologies (Diversigen)
Molecular Research LP
Charles River Laboratories International, Inc.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.

CHAPTER 1:INTRODUCTION: 1.1.Report description; 1.2.Key market segments; 1.3.Key benefits to the stakeholders; 1.4.Research Methodology; 1.4.1.Secondary research; 1.4.2.Primary research; 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY: 2.1.Key findings of the study; 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW: 3.1.Market definition and scope; 3.2.Key findings; 3.2.1.Top investment pockets; 3.3.Porter’s five forces analysis; 3.4.Market dynamics; 3.4.1.Drivers; 3.4.1.1. Rise in investment in microbiome research; 3.4.1.2. Use of microbiome in diagnosis of diseases; 3.4.1.3. Increase in collaborations and partnerships for microbiome research; 3.4.2.Restraints; 3.4.2.1. Ethical and legal limitations; 3.4.3.Opportunities; 3.4.3.1. Wide applications of microbiome research; 3.5.COVID-19 Impact Analysis on the market
CHAPTER 4: MICROBIOME SEQUENCING MARKET, BY TECHNIQUE: 4.1 Overview; 4.1.1 Market size and forecast; 4.2. Shotgun sequencing; 4.2.1 Key market trends, growth factors and opportunities; 4.2.2 Market size and forecast, by region; 4.2.3 Market share analysis by country; 4.3. RNA sequencing; 4.3.1 Key market trends, growth factors and opportunities; 4.3.2 Market size and forecast, by region; 4.3.3 Market share analysis by country; 4.4. Targeted gene sequencing; 4.4.1 Key market trends, growth factors and opportunities; 4.4.2 Market size and forecast, by region; 4.4.3 Market share analysis by country; 4.5. Whole genome sequencing; 4.5.1 Key market trends, growth factors and opportunities; 4.5.2 Market size and forecast, by region; 4.5.3 Market share analysis by country; 4.6. Others; 4.6.1 Key market trends, growth factors and opportunities; 4.6.2 Market size and forecast, by region; 4.6.3 Market share analysis by country
CHAPTER 5: MICROBIOME SEQUENCING MARKET, BY RESEARCH: 5.1 Overview; 5.1.1 Market size and forecast; 5.2. Outsourced; 5.2.1 Key market trends, growth factors and opportunities; 5.2.2 Market size and forecast, by region; 5.2.3 Market share analysis by country; 5.3. Internal; 5.3.1 Key market trends, growth factors and opportunities; 5.3.2 Market size and forecast, by region; 5.3.3 Market share analysis by country
CHAPTER 6: MICROBIOME SEQUENCING MARKET, BY END USER: 6.1 Overview; 6.1.1 Market size and forecast; 6.2. Pharmaceutical and biotechnological companies; 6.2.1 Key market trends, growth factors and opportunities; 6.2.2 Market size and forecast, by region; 6.2.3 Market share analysis by country; 6.3. Academic institutes and research centers; 6.3.1 Key market trends, growth factors and opportunities; 6.3.2 Market size and forecast, by region; 6.3.3 Market share analysis by country
CHAPTER 7: MICROBIOME SEQUENCING MARKET, BY REGION: 7.1 Overview; 7.1.1 Market size and forecast; 7.2 North America; 7.2.1 Key trends and opportunities; 7.2.2 North America Market size and forecast, by Technique; 7.2.3 North America Market size and forecast, by Research; 7.2.4 North America Market size and forecast, by End user; 7.2.5 North America Market size and forecast, by country; 7.2.5.1 U.S.; 7.2.5.1.1 Key market trends, growth factors and opportunities; 7.2.5.1.2 Market size and forecast, by Technique; 7.2.5.1.3 Market size and forecast, by Research; 7.2.5.1.4 Market size and forecast, by End user; 7.2.5.2 Canada; 7.2.5.2.1 Key market trends, growth factors and opportunities; 7.2.5.2.2 Market size and forecast, by Technique; 7.2.5.2.3 Market size and forecast, by Research; 7.2.5.2.4 Market size and forecast, by End user; 7.2.5.3 Mexico; 7.2.5.3.1 Key market trends, growth factors and opportunities; 7.2.5.3.2 Market size and forecast, by Technique; 7.2.5.3.3 Market size and forecast, by Research; 7.2.5.3.4 Market size and forecast, by End user; 7.3 Europe; 7.3.1 Key trends and opportunities; 7.3.2 Europe Market size and forecast, by Technique; 7.3.3 Europe Market size and forecast, by Research; 7.3.4 Europe Market size and forecast, by End user; 7.3.5 Europe Market size and forecast, by country; 7.3.5.1 Germany; 7.3.5.1.1 Key market trends, growth factors and opportunities; 7.3.5.1.2 Market size and forecast, by Technique; 7.3.5.1.3 Market size and forecast, by Research; 7.3.5.1.4 Market size and forecast, by End user; 7.3.5.2 UK; 7.3.5.2.1 Key market trends, growth factors and opportunities; 7.3.5.2.2 Market size and forecast, by Technique; 7.3.5.2.3 Market size and forecast, by Research; 7.3.5.2.4 Market size and forecast, by End user; 7.3.5.3 France; 7.3.5.3.1 Key market trends, growth factors and opportunities; 7.3.5.3.2 Market size and forecast, by Technique; 7.3.5.3.3 Market size and forecast, by Research; 7.3.5.3.4 Market size and forecast, by End user; 7.3.5.4 Italy; 7.3.5.4.1 Key market trends, growth factors and opportunities; 7.3.5.4.2 Market size and forecast, by Technique; 7.3.5.4.3 Market size and forecast, by Research; 7.3.5.4.4 Market size and forecast, by End user; 7.3.5.5 Spain; 7.3.5.5.1 Key market trends, growth factors and opportunities; 7.3.5.5.2 Market size and forecast, by Technique; 7.3.5.5.3 Market size and forecast, by Research; 7.3.5.5.4 Market size and forecast, by End user; 7.3.5.6 Rest of Europe; 7.3.5.6.1 Key market trends, growth factors and opportunities; 7.3.5.6.2 Market size and forecast, by Technique; 7.3.5.6.3 Market size and forecast, by Research; 7.3.5.6.4 Market size and forecast, by End user; 7.4 Asia-Pacific; 7.4.1 Key trends and opportunities; 7.4.2 Asia-Pacific Market size and forecast, by Technique; 7.4.3 Asia-Pacific Market size and forecast, by Research; 7.4.4 Asia-Pacific Market size and forecast, by End user; 7.4.5 Asia-Pacific Market size and forecast, by country; 7.4.5.1 Japan; 7.4.5.1.1 Key market trends, growth factors and opportunities; 7.4.5.1.2 Market size and forecast, by Technique; 7.4.5.1.3 Market size and forecast, by Research; 7.4.5.1.4 Market size and forecast, by End user; 7.4.5.2 China; 7.4.5.2.1 Key market trends, growth factors and opportunities; 7.4.5.2.2 Market size and forecast, by Technique; 7.4.5.2.3 Market size and forecast, by Research; 7.4.5.2.4 Market size and forecast, by End user; 7.4.5.3 India; 7.4.5.3.1 Key market trends, growth factors and opportunities; 7.4.5.3.2 Market size and forecast, by Technique; 7.4.5.3.3 Market size and forecast, by Research; 7.4.5.3.4 Market size and forecast, by End user; 7.4.5.4 Australia; 7.4.5.4.1 Key market trends, growth factors and opportunities; 7.4.5.4.2 Market size and forecast, by Technique; 7.4.5.4.3 Market size and forecast, by Research; 7.4.5.4.4 Market size and forecast, by End user; 7.4.5.5 South Korea; 7.4.5.5.1 Key market trends, growth factors and opportunities; 7.4.5.5.2 Market size and forecast, by Technique; 7.4.5.5.3 Market size and forecast, by Research; 7.4.5.5.4 Market size and forecast, by End user; 7.4.5.6 Rest of Asia-Pacific; 7.4.5.6.1 Key market trends, growth factors and opportunities; 7.4.5.6.2 Market size and forecast, by Technique; 7.4.5.6.3 Market size and forecast, by Research; 7.4.5.6.4 Market size and forecast, by End user; 7.5 LAMEA; 7.5.1 Key trends and opportunities; 7.5.2 LAMEA Market size and forecast, by Technique; 7.5.3 LAMEA Market size and forecast, by Research; 7.5.4 LAMEA Market size and forecast, by End user; 7.5.5 LAMEA Market size and forecast, by country; 7.5.5.1 Brazil; 7.5.5.1.1 Key market trends, growth factors and opportunities; 7.5.5.1.2 Market size and forecast, by Technique; 7.5.5.1.3 Market size and forecast, by Research; 7.5.5.1.4 Market size and forecast, by End user; 7.5.5.2 Saudi Arabia; 7.5.5.2.1 Key market trends, growth factors and opportunities; 7.5.5.2.2 Market size and forecast, by Technique; 7.5.5.2.3 Market size and forecast, by Research; 7.5.5.2.4 Market size and forecast, by End user; 7.5.5.3 South Africa; 7.5.5.3.1 Key market trends, growth factors and opportunities; 7.5.5.3.2 Market size and forecast, by Technique; 7.5.5.3.3 Market size and forecast, by Research; 7.5.5.3.4 Market size and forecast, by End user; 7.5.5.4 Rest of LAMEA; 7.5.5.4.1 Key market trends, growth factors and opportunities; 7.5.5.4.2 Market size and forecast, by Technique; 7.5.5.4.3 Market size and forecast, by Research; 7.5.5.4.4 Market size and forecast, by End user
CHAPTER 8: COMPETITIVE LANDSCAPE: 8.1. Introduction; 8.2. Top winning strategies; 8.3. Product Mapping of Top 10 Player; 8.4. Competitive Dashboard; 8.5. Competitive Heatmap; 8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES: 9.1 Microbiome Insights; 9.1.1 Company overview; 9.1.2 Key Executives; 9.1.3 Company snapshot; 9.1.4 Operating business segments; 9.1.5 Product portfolio; 9.1.6 Business performance; 9.1.7 Key strategic moves and developments; 9.2 Clinical Microbiomics; 9.2.1 Company overview; 9.2.2 Key Executives; 9.2.3 Company snapshot; 9.2.4 Operating business segments; 9.2.5 Product portfolio; 9.2.6 Business performance; 9.2.7 Key strategic moves and developments; 9.3 Baseclear BV; 9.3.1 Company overview; 9.3.2 Key Executives; 9.3.3 Company snapshot; 9.3.4 Operating business segments; 9.3.5 Product portfolio; 9.3.6 Business performance; 9.3.7 Key strategic moves and developments; 9.4 CosmosID; 9.4.1 Company overview; 9.4.2 Key Executives; 9.4.3 Company snapshot; 9.4.4 Operating business segments; 9.4.5 Product portfolio; 9.4.6 Business performance; 9.4.7 Key strategic moves and developments; 9.5 Novogene Co., Ltd.; 9.5.1 Company overview; 9.5.2 Key Executives; 9.5.3 Company snapshot; 9.5.4 Operating business segments; 9.5.5 Product portfolio; 9.5.6 Business performance; 9.5.7 Key strategic moves and developments; 9.6 Zymo Research Corporation; 9.6.1 Company overview; 9.6.2 Key Executives; 9.6.3 Company snapshot; 9.6.4 Operating business segments; 9.6.5 Product portfolio; 9.6.6 Business performance; 9.6.7 Key strategic moves and developments; 9.7 Resphera Biosciences, LLC; 9.7.1 Company overview; 9.7.2 Key Executives; 9.7.3 Company snapshot; 9.7.4 Operating business segments; 9.7.5 Product portfolio; 9.7.6 Business performance; 9.7.7 Key strategic moves and developments; 9.8 OraSure Technologies (Diversigen); 9.8.1 Company overview; 9.8.2 Key Executives; 9.8.3 Company snapshot; 9.8.4 Operating business segments; 9.8.5 Product portfolio; 9.8.6 Business performance; 9.8.7 Key strategic moves and developments; 9.9 Molecular Research LP; 9.9.1 Company overview; 9.9.2 Key Executives; 9.9.3 Company snapshot; 9.9.4 Operating business segments; 9.9.5 Product portfolio; 9.9.6 Business performance; 9.9.7 Key strategic moves and developments; 9.10 Charles River Laboratories International, Inc.; 9.10.1 Company overview; 9.10.2 Key Executives; 9.10.3 Company snapshot; 9.10.4 Operating business segments; 9.10.5 Product portfolio; 9.10.6 Business performance; 9.10.7 Key strategic moves and developments
LIST OF TABLES: TABLE 1. GLOBAL MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 2. MICROBIOME SEQUENCING MARKET FOR SHOTGUN SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 3. MICROBIOME SEQUENCING MARKET FOR RNA SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 4. MICROBIOME SEQUENCING MARKET FOR TARGETED GENE SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 5. MICROBIOME SEQUENCING MARKET FOR WHOLE GENOME SEQUENCING, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 6. MICROBIOME SEQUENCING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 7. GLOBAL MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 8. MICROBIOME SEQUENCING MARKET FOR OUTSOURCED, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 9. MICROBIOME SEQUENCING MARKET FOR INTERNAL, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 10. GLOBAL MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 11. MICROBIOME SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 12. MICROBIOME SEQUENCING MARKET FOR ACADEMIC INSTITUTES AND RESEARCH CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 13. MICROBIOME SEQUENCING MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION); TABLE 14. NORTH AMERICA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 15. NORTH AMERICA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 16. NORTH AMERICA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 17. NORTH AMERICA MICROBIOME SEQUENCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION); TABLE 18. U.S. MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 19. U.S. MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 20. U.S. MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 21. CANADA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 22. CANADA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 23. CANADA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 24. MEXICO MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 25. MEXICO MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 26. MEXICO MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 27. EUROPE MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 28. EUROPE MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 29. EUROPE MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 30. EUROPE MICROBIOME SEQUENCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION); TABLE 31. GERMANY MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 32. GERMANY MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 33. GERMANY MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 34. UK MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 35. UK MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 36. UK MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 37. FRANCE MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 38. FRANCE MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 39. FRANCE MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 40. ITALY MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 41. ITALY MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 42. ITALY MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 43. SPAIN MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 44. SPAIN MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 45. SPAIN MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 46. REST OF EUROPE MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 47. REST OF EUROPE MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 48. REST OF EUROPE MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 49. ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 50. ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 51. ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 52. ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION); TABLE 53. JAPAN MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 54. JAPAN MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 55. JAPAN MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 56. CHINA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 57. CHINA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 58. CHINA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 59. INDIA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 60. INDIA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 61. INDIA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 62. AUSTRALIA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 63. AUSTRALIA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 64. AUSTRALIA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 65. SOUTH KOREA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 66. SOUTH KOREA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 67. SOUTH KOREA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 68. REST OF ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 69. REST OF ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 70. REST OF ASIA-PACIFIC MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 71. LAMEA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 72. LAMEA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 73. LAMEA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 74. LAMEA MICROBIOME SEQUENCING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION); TABLE 75. BRAZIL MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 76. BRAZIL MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 77. BRAZIL MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 78. SAUDI ARABIA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 79. SAUDI ARABIA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 80. SAUDI ARABIA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 81. SOUTH AFRICA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 82. SOUTH AFRICA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 83. SOUTH AFRICA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 84. REST OF LAMEA MICROBIOME SEQUENCING MARKET, BY TECHNIQUE, 2021-2031 (REVENUE, $MILLION); TABLE 85. REST OF LAMEA MICROBIOME SEQUENCING MARKET, BY RESEARCH, 2021-2031 (REVENUE, $MILLION); TABLE 86. REST OF LAMEA MICROBIOME SEQUENCING MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION); TABLE 87. MICROBIOME INSIGHTS: KEY EXECUTIVES; TABLE 88. MICROBIOME INSIGHTS: COMPANY SNAPSHOT; TABLE 89. MICROBIOME INSIGHTS: OPERATING SEGMENTS; TABLE 90. MICROBIOME INSIGHTS: PRODUCT PORTFOLIO; TABLE 91. MICROBIOME INSIGHTS: NET SALES; TABLE 92. MICROBIOME INSIGHTS: KEY STRATERGIES; TABLE 93. CLINICAL MICROBIOMICS: KEY EXECUTIVES; TABLE 94. CLINICAL MICROBIOMICS: COMPANY SNAPSHOT; TABLE 95. CLINICAL MICROBIOMICS: OPERATING SEGMENTS; TABLE 96. CLINICAL MICROBIOMICS: PRODUCT PORTFOLIO; TABLE 97. CLINICAL MICROBIOMICS: NET SALES; TABLE 98. CLINICAL MICROBIOMICS: KEY STRATERGIES; TABLE 99. BASECLEAR BV: KEY EXECUTIVES; TABLE 100. BASECLEAR BV: COMPANY SNAPSHOT; TABLE 101. BASECLEAR BV: OPERATING SEGMENTS; TABLE 102. BASECLEAR BV: PRODUCT PORTFOLIO; TABLE 103. BASECLEAR BV: NET SALES; TABLE 104. BASECLEAR BV: KEY STRATERGIES; TABLE 105. COSMOSID: KEY EXECUTIVES; TABLE 106. COSMOSID: COMPANY SNAPSHOT; TABLE 107. COSMOSID: OPERATING SEGMENTS; TABLE 108. COSMOSID: PRODUCT PORTFOLIO; TABLE 109. COSMOSID: NET SALES; TABLE 110. COSMOSID: KEY STRATERGIES; TABLE 111. NOVOGENE CO., LTD. : KEY EXECUTIVES; TABLE 112. NOVOGENE CO., LTD. : COMPANY SNAPSHOT; TABLE 113. NOVOGENE CO., LTD. : OPERATING SEGMENTS; TABLE 114. NOVOGENE CO., LTD. : PRODUCT PORTFOLIO; TABLE 115. NOVOGENE CO., LTD. : NET SALES; TABLE 116. NOVOGENE CO., LTD. : KEY STRATERGIES; TABLE 117. ZYMO RESEARCH CORPORATION: KEY EXECUTIVES; TABLE 118. ZYMO RESEARCH CORPORATION: COMPANY SNAPSHOT; TABLE 119. ZYMO RESEARCH CORPORATION: OPERATING SEGMENTS; TABLE 120. ZYMO RESEARCH CORPORATION: PRODUCT PORTFOLIO; TABLE 121. ZYMO RESEARCH CORPORATION: NET SALES; TABLE 122. ZYMO RESEARCH CORPORATION: KEY STRATERGIES; TABLE 123. RESPHERA BIOSCIENCES, LLC: KEY EXECUTIVES; TABLE 124. RESPHERA BIOSCIENCES, LLC: COMPANY SNAPSHOT; TABLE 125. RESPHERA BIOSCIENCES, LLC: OPERATING SEGMENTS; TABLE 126. RESPHERA BIOSCIENCES, LLC: PRODUCT PORTFOLIO; TABLE 127. RESPHERA BIOSCIENCES, LLC: NET SALES; TABLE 128. RESPHERA BIOSCIENCES, LLC: KEY STRATERGIES; TABLE 129. ORASURE TECHNOLOGIES (DIVERSIGEN): KEY EXECUTIVES; TABLE 130. ORASURE TECHNOLOGIES (DIVERSIGEN): COMPANY SNAPSHOT; TABLE 131. ORASURE TECHNOLOGIES (DIVERSIGEN): OPERATING SEGMENTS; TABLE 132. ORASURE TECHNOLOGIES (DIVERSIGEN): PRODUCT PORTFOLIO; TABLE 133. ORASURE TECHNOLOGIES (DIVERSIGEN): NET SALES; TABLE 134. ORASURE TECHNOLOGIES (DIVERSIGEN): KEY STRATERGIES; TABLE 135. MOLECULAR RESEARCH LP: KEY EXECUTIVES; TABLE 136. MOLECULAR RESEARCH LP: COMPANY SNAPSHOT; TABLE 137. MOLECULAR RESEARCH LP: OPERATING SEGMENTS; TABLE 138. MOLECULAR RESEARCH LP: PRODUCT PORTFOLIO; TABLE 139. MOLECULAR RESEARCH LP: NET SALES; TABLE 140. MOLECULAR RESEARCH LP: KEY STRATERGIES; TABLE 141. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY EXECUTIVES; TABLE 142. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT; TABLE 143. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: OPERATING SEGMENTS; TABLE 144. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: PRODUCT PORTFOLIO; TABLE 145. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: NET SALES; TABLE 146. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: KEY STRATERGIES
LIST OF FIGURES: FIGURE 1. SEGMENTATION OF MICROBIOME SEQUENCING MARKET,2021-2031; FIGURE 2. MICROBIOME SEQUENCING MARKET,2021-2031; FIGURE 3. TOP INVESTMENT POCKETS, BY REGION; FIGURE 4. PORTER FIVE-1; FIGURE 5. PORTER FIVE-2; FIGURE 6. PORTER FIVE-3; FIGURE 7. PORTER FIVE-4; FIGURE 8. PORTER FIVE-5; FIGURE 9. MICROBIOME SEQUENCING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES; FIGURE 10. MICROBIOME SEQUENCING MARKET,BY TECHNIQUE,2021(%); FIGURE 11. COMPARATIVE SHARE ANALYSIS OF SHOTGUN SEQUENCING MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 12. COMPARATIVE SHARE ANALYSIS OF RNA SEQUENCING MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 13. COMPARATIVE SHARE ANALYSIS OF TARGETED GENE SEQUENCING MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 14. COMPARATIVE SHARE ANALYSIS OF WHOLE GENOME SEQUENCING MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 15. COMPARATIVE SHARE ANALYSIS OF OTHERS MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 16. MICROBIOME SEQUENCING MARKET,BY RESEARCH,2021(%); FIGURE 17. COMPARATIVE SHARE ANALYSIS OF OUTSOURCED MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 18. COMPARATIVE SHARE ANALYSIS OF INTERNAL MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 19. MICROBIOME SEQUENCING MARKET,BY END USER,2021(%); FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 21. COMPARATIVE SHARE ANALYSIS OF ACADEMIC INSTITUTES AND RESEARCH CENTERS MICROBIOME SEQUENCING MARKET, 2021 AND 2031(%); FIGURE 22. MICROBIOME SEQUENCING MARKET BY REGION,2021; FIGURE 23. U.S. MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 24. CANADA MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 25. MEXICO MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 26. GERMANY MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 27. UK MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 28. FRANCE MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 29. ITALY MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 30. SPAIN MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 31. REST OF EUROPE MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 32. JAPAN MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 33. CHINA MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 34. INDIA MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 35. AUSTRALIA MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 36. SOUTH KOREA MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 37. REST OF ASIA-PACIFIC MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 38. BRAZIL MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 39. SAUDI ARABIA MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 40. SOUTH AFRICA MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 41. REST OF LAMEA MICROBIOME SEQUENCING MARKET,2021-2031($MILLION); FIGURE 42. TOP WINNING STRATEGIES, BY YEAR; FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT; FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY; FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS; FIGURE 46. COMPETITIVE DASHBOARD; FIGURE 47. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS; FIGURE 48. TOP PLAYER POSITIONING, 2021; FIGURE 49. MICROBIOME INSIGHTS.: NET SALES ($MILLION); FIGURE 50. CLINICAL MICROBIOMICS.: NET SALES ($MILLION); FIGURE 51. BASECLEAR BV.: NET SALES ($MILLION); FIGURE 52. COSMOSID.: NET SALES ($MILLION); FIGURE 53. NOVOGENE CO., LTD. .: NET SALES ($MILLION); FIGURE 54. ZYMO RESEARCH CORPORATION.: NET SALES ($MILLION); FIGURE 55. RESPHERA BIOSCIENCES, LLC.: NET SALES ($MILLION); FIGURE 56. ORASURE TECHNOLOGIES (DIVERSIGEN).: NET SALES ($MILLION); FIGURE 57. MOLECULAR RESEARCH LP.: NET SALES ($MILLION); FIGURE 58. CHARLES RIVER LABORATORIES INTERNATIONAL, INC..: NET SALES ($MILLION)